Empirical Wealth Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
WF
VF
AT
AS
TIM
WTA
CISOA
Empirical Wealth Management's RMD Position: Q2 2026 in Review
Empirical Wealth Management reduced its ResMed (RMD) stake by 34% in Q2 2026, selling an estimated $211K and leaving 1,950 shares worth $380K. The position accounts for 0.01% of the portfolio, ranked #793.
Empirical Wealth Management first reported a position in RMD in Q1 2021 and has held it in 10 quarters since. The position peaked at $6.37M in Q2 2025. 301 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Empirical Wealth Management held 1,950 shares of ResMed worth $380K as of Q2 2026.
- Empirical Wealth Management sold 1,020 ResMed shares in Q2 2026, an estimated $211K.
- ResMed made up 0.01% of Empirical Wealth Management's portfolio in Q2 2026, its #793 holding.
- Empirical Wealth Management first reported a position in ResMed in Q1 2021 and has held it in 10 quarters since.
- Empirical Wealth Management's ResMed position peaked at $6.37M in Q2 2025.
- 301 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Empirical Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.